CN Patent

CN1788001A — 可用于治疗赘生性疾病、炎性和免疫系统病症的2,4－二(苯氨基)嘧啶

Assigned to Novartis AG · Expires 2006-06-14 · 20y expired

What this patent protects

本发明公开了式(I)的新嘧啶衍生物，它们的制备方法、它们作为药物用于治疗赘生性疾病、炎性和免疫系统病症的用途和包含它们的药物组合物。

USPTO Abstract

本发明公开了式(I)的新嘧啶衍生物，它们的制备方法、它们作为药物用于治疗赘生性疾病、炎性和免疫系统病症的用途和包含它们的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN1788001A
Jurisdiction
CN
Classification
—
Expires
2006-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.